Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Fasciotomy and Predilation for Radial Artery Grafts in CABG

Official title: Effect of Pedicled Harvesting With FascIotomy and PreDilation on Radial Artery Graft Outcomes After Coronary Artery Bypass Grafting: A Multicenter, Randomized, Participant and Assessor Blinded, Parallel- Controlled, Superiority Trial

Run by Ruijin Hospital · NCT07868692 · Data updated 2026-11-12

A new way to prepare radial artery grafts during CABG is tested to see if it lowers complications and improves graft durability for adults undergoing this heart surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment314 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedOctober 13, 2026
Main results expectedDecember 2028
Study endsJune 2029
Registry record updatedOctober 27, 2026
Trial IDNCT07868692 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for CABG who plan to use radial artery grafts and can provide informed consent.

Probably not a fit

Patients who do not receive radial artery grafts or who have contraindications to the procedure or to imaging follow-up may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests whether performing fasciotomy and predilation on radial artery grafts during CABG improves outcomes compared with the standard harvesting method. The approach involves a small tissue release around the graft and pre-procedure dilation with a solution to assess and potentially reduce graft damage. Participants are adults planned for CABG who will receive radial artery grafts. The trial looks at death, heart attack, need for additional procedures, graft failure, and blood flow at 1 year, with safety monitoring throughout. The study is conducted at Ruijin Hospital in Shanghai, led by Ruijin Hospital with no listed collaborators.

Why it matters

Potential benefit: If successful, this approach could reduce graft-related complications and improve long-term patency of radial artery grafts after CABG.

How similar studies have gone: Previous research on refining graft preparation has shown potential, but this exact fasciotomy and predilation method is being evaluated for its impact.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled for coronary artery bypass grafting (CABG) and planned use of radial artery (RA) grafts

Exclusion Criteria:

* Emergency CABG or redo CABG
* Planned concomitant cardiac or non-cardiac surgery
* Contraindications to coronary computed tomography angiography (CCTA), including pregnancy, uncontrolled severe iodine contrast allergy, or severe renal insufficiency (eGFR \< 30 mL/min/1.73 m²)
* Any condition that, in the investigator's judgment, would preclude safe participation, completion of informed consent, or follow-up
* Inability to provide written informed consent

Where it's running

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Yunpeng Zhu — Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Study coordinator: Yunpeng Zhu
  • Email: zyp12220@rjh.com.cn
  • Phone: +86 02164370045

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.